What is Iovance Biotherapeutics, Inc.'s change in other assets?

Iovance Biotherapeutics, Inc. (IOVA) reported change in other assets of $1.47M in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s change in other assets changed year-over-year?

Iovance Biotherapeutics, Inc.'s change in other assets decreased by 54.9% year-over-year, from $3.25M to $1.47M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Iovance Biotherapeutics, Inc. IOVA Change in Other Assets

Change in Other Assets at other companies

ImmunomeIMNM

$5.1M+199%

Nuvation BioNUVB

-$3.78M-2,509%

ImmunityBio, Inc.IBRX

$1.05M+1,152%

Immunovant, Inc.IMVT

-$1.3M-767%

Viridian Therapeutics, Inc.VRDN

$2.33M+919%

Protagonist TherapeuticsPTGX

$1.92M+102%

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

CapEx$6.6M+6.4%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.98B+32.4%

Enterprise value$1.83B+33.2%

P/S6.9×-0.1×

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s change in other assets?: Iovance Biotherapeutics, Inc. (IOVA) reported change in other assets of $1.47M in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s change in other assets changed year-over-year?: Iovance Biotherapeutics, Inc.'s change in other assets decreased by 54.9% year-over-year, from $3.25M to $1.47M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.